The Advances and Progress in Drug Design 2012 is a conference that covers topics such as:
- Six Sigma - a tool to enhance drug design
- Strategies to increase the clinical success of the product
- Novel targets in drug discovery
- Protein-protein interactions
- Computational tools for reducing drug toxicity
- The latest in rational drug design
- Opportunities in outsourcing drug design
The Advances and Progress in Drug Design 2012 brings together VPs, Directors, Senior Managers, Heads, Biotech, Principal Scientists in Pharmaceutical and Academics from:
- Structure and Informatics
- Outsourcing
- Computational Chemistry
- Computer-aided Drug Design
- Cancer Pharmacology
- Cancer Research
- Pharmacology
- Medicinal Chemistry
- Drug Discovery & Design
- Molecular Imaging
- Molecular Discovery
- Target Discovery
- Target Discovery
- Drug Development
- Biophysics
- Translational Sciences
- Structural Biology
- Clinical Development
